SEC SANCTIONS EX-CEO FOR ALLEGED MISAPPROPRIATION

The former head of a biotech startup, who allegedly misappropriated US$3.2 million from his company, is being sanctioned in a set...


You need to be a subscriber to view this article. It's free!

CN Editor

May 05, 2026